We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Procter & Gamble Stock Looks Pricey: What's the Best Move Now?
Read MoreHide Full Article
Key Takeaways
Procter & Gamble trades at 20.22X forward P/E, above the industry's 18.12X and key peers.
Shares fell 4.5% in three months, underperforming the industry, sector and S&P 500 over the same period.
Cost pressures and soft growth temper innovation and productivity gains, favoring patience at current levels.
The Procter & Gamble Company (PG - Free Report) continues to benefit from its strong market position, supported by ongoing productivity initiatives and a focus on cost efficiency. From a valuation standpoint, however, the stock presents a mixed picture. PG currently trades at a forward 12-month price-to-earnings (P/E) ratio of 20.22X, below its five-year median of 23.34X. Despite this discount to its historical valuation, the multiple remains above the Zacks Consumer Products – Staples industry average of 18.12X, indicating that the stock commands a premium relative to its peers.
A similar premium is evident on a price-to-sales (P/S) basis. Procter & Gamble’s P/S ratio of 3.73X stands well above the industry multiple of 2.22X. This relatively elevated valuation may limit the stock’s appeal for value-oriented investors, particularly given its Value Score of D. Taken together, these valuation metrics suggest that while PG is trading below its own historical P/E median, its premium relative to the industry warrants some caution at current levels.
Image Source: Zacks Investment Research
PG’s Premium Valuation Surpasses Peers
At a forward 12-month P/E multiple of 20.22X, Procter & Gamble trades at a notable premium to its peers, including The Clorox Company (CLX - Free Report) , Unilever PLC (UL - Free Report) and Albertsons Companies, Inc. (ACI - Free Report) .
Clorox, Unilever and Albertsons Companies currently trade at forward P/E multiples of 15.01X, 16.73X and 7.03X, respectively — all well below PG’s valuation. This wide valuation gap suggests that investors are assigning a sizable premium to Procter & Gamble, making the stock appear relatively expensive compared with these peers.
PG’s elevated valuation also implies that the market is pricing in strong expectations for its future performance. While its brand strength, scale and execution capabilities may support a premium multiple, the current valuation leaves less room for disappointment. Procter & Gamble will need to deliver sustained earnings growth and solid operating performance to justify this premium. Until then, the stock appears somewhat overvalued relative to its peer group.
Despite trading at a premium valuation, Procter & Gamble’s shares have remained under pressure in recent months. In the past three months, PG stock has lost 4.5% compared with a 2.3% decline for the broader industry. The stock has also underperformed the Zacks Consumer Staples sector, which fell 1.6%, as well as the S&P 500, which gained 1.9% in the same period.
PG’s 3-Month Performance
Image Source: Zacks Investment Research
Nevertheless, Procter & Gamble has fared better than some of its peers. Shares of Clorox and Albertsons Companies have declined 8.3% and 24.1%, respectively, in the past three months. However, PG has lagged Unilever, whose shares advanced 4.6% in the same period.
At its current share price of $142.97, PG trades 14.5% below its 52-week high of $167.25 and 3.9% above its 52-week low of $137.62. The stock is also trading below its 50-day and 200-day moving averages, pointing to continued weakness in near-term price momentum. Moving averages are widely used technical indicators that help assess prevailing stock-price trends and market momentum.
Procter & Gamble Trades Below 50 & 200-Day SMA
Image Source: Zacks Investment Research
PG’s Growth Drivers vs. Market Challenges
Procter & Gamble’s growth outlook is supported by its integrated strategy centered on product superiority, innovation, productivity and stronger consumer engagement. Management highlighted improving global share trends, broad-based organic sales growth across most categories and regions, and solid momentum in markets such as Greater China and Latin America.
The company is also strengthening its core brands through product upgrades while expanding into adjacent growth opportunities. Tide’s upgraded liquid detergent, Tide evo, premium Baby Care products in China and stronger digital commerce execution illustrate how PG is using innovation to drive user growth, category expansion and market-share gains.
At the same time, productivity remains a key enabler, allowing the company to fund brand investment, media, R&D and supply-chain capabilities while supporting profitability. Procter & Gamble is also scaling AI-enabled brand building, data-driven work processes and Supply Chain 3.0 to improve speed, execution and consumer reach.
However, the operating environment remains challenging. Management expects continued volatility across consumer demand, commodities, currencies, retail dynamics and geopolitics. Fiscal 2027 guidance assumes only 1-3% organic sales growth, with restructuring creating a 30-50 basis-point headwind.
Higher raw-material, energy, transportation and supply-chain costs are expected to create about $1 billion of after-tax pressure, while foreign exchange, interest expense and lower nonoperating income add further strain. Slower category growth in North America and Europe, rising promotional intensity and continued consumer value sensitivity also pose risks.
Procter & Gamble therefore needs sustained innovation, disciplined pricing and productivity gains to offset cost pressures and return to stronger, balanced growth in the coming fiscal year.
PG’s Estimate Revision Trend
The Zacks Consensus Estimate for Procter & Gamble’s fiscal 2027 EPS has moved down 0.3% in the past 30 days. Meanwhile, the consensus mark for fiscal 2028 EPS has been unchanged in the past 30 days.
For fiscal 2027, the Zacks Consensus Estimate for PG’s revenues and EPS implies year-over-year growth of 1.8% and 1.5%, respectively. The consensus mark for fiscal 2028 revenues and EPS indicates 2.7% and 6.2% growth year over year, respectively.
Image Source: Zacks Investment Research
How to Play PG Stock Now?
Procter & Gamble’s premium valuation makes the stock relatively expensive compared with the broader industry and several key peers. Nevertheless, the elevated multiple also suggests that investors continue to place considerable confidence in the company’s strong brands, market position, innovation capabilities and long-term earnings potential, despite the recent weakness in its share price.
While productivity initiatives, portfolio strength and improving market-share trends remain encouraging, near-term growth is constrained by cost inflation, softer category growth, consumer value sensitivity and other macroeconomic uncertainties. Moreover, downward estimate revisions for fiscal 2027 warrant some caution.
Given this balance of solid underlying fundamentals and a demanding valuation, investors may prefer to retain their positions rather than chase the stock at current levels. Holding this Zacks Rank #3 (Hold) stock appears prudent until there is greater clarity on PG’s growth trajectory, margin recovery and ability to justify its premium valuation. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
View the Zacks #1 Rank List
Image: Bigstock
Procter & Gamble Stock Looks Pricey: What's the Best Move Now?
Key Takeaways
The Procter & Gamble Company (PG - Free Report) continues to benefit from its strong market position, supported by ongoing productivity initiatives and a focus on cost efficiency. From a valuation standpoint, however, the stock presents a mixed picture. PG currently trades at a forward 12-month price-to-earnings (P/E) ratio of 20.22X, below its five-year median of 23.34X. Despite this discount to its historical valuation, the multiple remains above the Zacks Consumer Products – Staples industry average of 18.12X, indicating that the stock commands a premium relative to its peers.
A similar premium is evident on a price-to-sales (P/S) basis. Procter & Gamble’s P/S ratio of 3.73X stands well above the industry multiple of 2.22X. This relatively elevated valuation may limit the stock’s appeal for value-oriented investors, particularly given its Value Score of D. Taken together, these valuation metrics suggest that while PG is trading below its own historical P/E median, its premium relative to the industry warrants some caution at current levels.
Image Source: Zacks Investment Research
PG’s Premium Valuation Surpasses Peers
At a forward 12-month P/E multiple of 20.22X, Procter & Gamble trades at a notable premium to its peers, including The Clorox Company (CLX - Free Report) , Unilever PLC (UL - Free Report) and Albertsons Companies, Inc. (ACI - Free Report) .
Clorox, Unilever and Albertsons Companies currently trade at forward P/E multiples of 15.01X, 16.73X and 7.03X, respectively — all well below PG’s valuation. This wide valuation gap suggests that investors are assigning a sizable premium to Procter & Gamble, making the stock appear relatively expensive compared with these peers.
PG’s elevated valuation also implies that the market is pricing in strong expectations for its future performance. While its brand strength, scale and execution capabilities may support a premium multiple, the current valuation leaves less room for disappointment. Procter & Gamble will need to deliver sustained earnings growth and solid operating performance to justify this premium. Until then, the stock appears somewhat overvalued relative to its peer group.
Despite trading at a premium valuation, Procter & Gamble’s shares have remained under pressure in recent months. In the past three months, PG stock has lost 4.5% compared with a 2.3% decline for the broader industry. The stock has also underperformed the Zacks Consumer Staples sector, which fell 1.6%, as well as the S&P 500, which gained 1.9% in the same period.
PG’s 3-Month Performance
Image Source: Zacks Investment Research
Nevertheless, Procter & Gamble has fared better than some of its peers. Shares of Clorox and Albertsons Companies have declined 8.3% and 24.1%, respectively, in the past three months. However, PG has lagged Unilever, whose shares advanced 4.6% in the same period.
At its current share price of $142.97, PG trades 14.5% below its 52-week high of $167.25 and 3.9% above its 52-week low of $137.62. The stock is also trading below its 50-day and 200-day moving averages, pointing to continued weakness in near-term price momentum. Moving averages are widely used technical indicators that help assess prevailing stock-price trends and market momentum.
Procter & Gamble Trades Below 50 & 200-Day SMA
Image Source: Zacks Investment Research
PG’s Growth Drivers vs. Market Challenges
Procter & Gamble’s growth outlook is supported by its integrated strategy centered on product superiority, innovation, productivity and stronger consumer engagement. Management highlighted improving global share trends, broad-based organic sales growth across most categories and regions, and solid momentum in markets such as Greater China and Latin America.
The company is also strengthening its core brands through product upgrades while expanding into adjacent growth opportunities. Tide’s upgraded liquid detergent, Tide evo, premium Baby Care products in China and stronger digital commerce execution illustrate how PG is using innovation to drive user growth, category expansion and market-share gains.
At the same time, productivity remains a key enabler, allowing the company to fund brand investment, media, R&D and supply-chain capabilities while supporting profitability. Procter & Gamble is also scaling AI-enabled brand building, data-driven work processes and Supply Chain 3.0 to improve speed, execution and consumer reach.
However, the operating environment remains challenging. Management expects continued volatility across consumer demand, commodities, currencies, retail dynamics and geopolitics. Fiscal 2027 guidance assumes only 1-3% organic sales growth, with restructuring creating a 30-50 basis-point headwind.
Higher raw-material, energy, transportation and supply-chain costs are expected to create about $1 billion of after-tax pressure, while foreign exchange, interest expense and lower nonoperating income add further strain. Slower category growth in North America and Europe, rising promotional intensity and continued consumer value sensitivity also pose risks.
Procter & Gamble therefore needs sustained innovation, disciplined pricing and productivity gains to offset cost pressures and return to stronger, balanced growth in the coming fiscal year.
PG’s Estimate Revision Trend
The Zacks Consensus Estimate for Procter & Gamble’s fiscal 2027 EPS has moved down 0.3% in the past 30 days. Meanwhile, the consensus mark for fiscal 2028 EPS has been unchanged in the past 30 days.
For fiscal 2027, the Zacks Consensus Estimate for PG’s revenues and EPS implies year-over-year growth of 1.8% and 1.5%, respectively. The consensus mark for fiscal 2028 revenues and EPS indicates 2.7% and 6.2% growth year over year, respectively.
Image Source: Zacks Investment Research
How to Play PG Stock Now?
Procter & Gamble’s premium valuation makes the stock relatively expensive compared with the broader industry and several key peers. Nevertheless, the elevated multiple also suggests that investors continue to place considerable confidence in the company’s strong brands, market position, innovation capabilities and long-term earnings potential, despite the recent weakness in its share price.
While productivity initiatives, portfolio strength and improving market-share trends remain encouraging, near-term growth is constrained by cost inflation, softer category growth, consumer value sensitivity and other macroeconomic uncertainties. Moreover, downward estimate revisions for fiscal 2027 warrant some caution.
Given this balance of solid underlying fundamentals and a demanding valuation, investors may prefer to retain their positions rather than chase the stock at current levels. Holding this Zacks Rank #3 (Hold) stock appears prudent until there is greater clarity on PG’s growth trajectory, margin recovery and ability to justify its premium valuation. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.